1 results
Not applicableRecruiting
Primary objectives: Improvement of CR2 rates after induction with ALL R3 with bortezomib versus without bortezomib in HR relapsed ALL patients Secondary objectives: Improvement of Event Free Survival (EFS) and overall survival (OS) rates…